Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 206 of 1,261
  1. US 11596633

    SHP2 inhibitor compositions and methods for treating cancer

    Revolution Medicines, Inc. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  2. US 11596909

    System and method for droplet formation and manipulation using ferrofluids

    The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  3. US 11596610

    Compositions in support of health and mental accuity

    HIGHER OPTIONS GLOBAL, INC. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  4. US 11597701

    Integrin ligands and uses thereof

    Arrowhead Pharmaceuticals, Inc. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  5. US 11596711

    Solubilization of antigen components for removal from tissues

    The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  6. US 11597853

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  7. US 11596694

    Compositions and methods for predicting response to NaPi2b-targeted therapy

    Mersana Therapeutics, Inc. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  8. US 11596585

    Composition for the prevention of microbial growth

    Eikonic R&D Pty Ltd · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  9. US 11596671

    Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with increased expression

    Takeda Pharmaceutical Company Limited · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  10. US 11596611

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  11. US 11596690

    Stabilized formulations containing anti-IL-33 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  12. US 11596696

    Combination therapy with an anti-CD25 antibody-drug conjugate

    ADC THERAPEUTICS SA · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  13. US 11598782

    Biomarkers and methods for detection of seizures and epilepsy

    Cognizance Biomarkers, LLC · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  14. US 11596688

    Predicting outcome of treatment with an anti-α4β7 integrin antibody

    Takeda Pharmaceutical Company Limited · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  15. US 11597707

    CGAS antagonist compounds

    The Board of Regents of the University of Texas System · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  16. IL 300192

    Manufacturing of dimeric contrast agents

    BRACCO IMAGING SPA [IT] · Granted Mar 1, 2023 · Expires Feb 24, 2043

    granted
  17. US 11594135

    Methods of CD40 activation and immune checkpoint blockade

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  18. US 11591350

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  19. US 11591319

    Small molecule inducers of autophagy

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  20. US 11590092

    Skin probiotic

    The Regents of the University of California · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  21. US 11591332

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  22. US 11591372

    Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  23. US 11591330

    HIF-2a small-molecule inhibitor and use thereof

    China Medical University · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  24. US 11590205

    Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents

    XERIS PHARMACEUTICALS, INC. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.